Wasatch Advisors LP Buys 110,010 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Wasatch Advisors LP boosted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 11.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,043,240 shares of the company’s stock after buying an additional 110,010 shares during the period. Wasatch Advisors LP owned approximately 5.75% of Addus HomeCare worth $138,782,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in ADUS. UMB Bank n.a. increased its position in Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares in the last quarter. Quest Partners LLC acquired a new position in Addus HomeCare during the 2nd quarter valued at about $31,000. Innealta Capital LLC acquired a new position in Addus HomeCare during the 2nd quarter valued at about $44,000. Farther Finance Advisors LLC increased its position in Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares in the last quarter. Finally, Sandia Investment Management LP acquired a new position in Addus HomeCare during the 2nd quarter valued at about $58,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on ADUS shares. Macquarie reaffirmed an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp started coverage on Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. TD Cowen boosted their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Royal Bank of Canada reiterated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. Finally, Oppenheimer boosted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and an average price target of $131.63.

Insider Buying and Selling

In related news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This represents a 12.93 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,500 shares of company stock valued at $1,668,265. 4.60% of the stock is owned by company insiders.

Addus HomeCare Stock Up 1.3 %

Shares of ADUS opened at $122.84 on Friday. Addus HomeCare Co. has a 52 week low of $85.43 and a 52 week high of $136.12. The company has a market capitalization of $2.23 billion, a price-to-earnings ratio of 28.11, a PEG ratio of 2.12 and a beta of 1.04. The stock’s 50-day moving average price is $127.30 and its 200-day moving average price is $123.57.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the prior year, the business earned $1.03 earnings per share. The company’s revenue was up 7.1% compared to the same quarter last year. As a group, equities analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.